Use of ivermectin, hydroxychloroquine, favipiravir dropped from new COVID-19 treatment guidelines
New Delhi: The Union Health Ministry on Monday dropped the use of ivermectin, hydroxychloroquine, and the anti-viral favipiravir from its COVID-19 treatment guidelines.
The nine-page guidelines have not mentioned the use of these medicines which have been used widely by doctors to treat Covid-19 patients.
Earlier guidelines given by Indian Council of Medical Research (ICMR) has mentioned the use of ivermectin in certain quantity only.
The use of medicines such as zinc, multivitamins, etc. prescribed by the doctors to asymptomatic or mildly symptomatic Covid-19 is also not mentioned except the use of Anti-Pyretic and Anti-tussive for symptomatic relief.
Guidelines for rational use of CT (HRCT)
The revised guidelines issued on May 27, also issue guidelines for the rational use of CT (HRCT) with reasons that why, when and what are those appropriate indications indication for HRCT imaging of the chest in COVID-19 patients.
Further, the Directorate General of Health's (DGH) COVID-19 guidelines stressed the importance of a monitoring sheet for Covid-19 patients at home and a six-minute simple clinical test to assess cardiopulmonary exercise tolerance.
The guidelines have stressed the use of wearing masks, physical distancing and hand hygiene.
The guidelines have mentioned the use of Remedesivir and it is advised to be used only in select moderate/severe hospitalised COVID-19 patients on supplemental oxygen within 10 days of onset of disease.
The guidelines for use of Tocilizumab which is an immunosuppressant drug was also mentioned in the guidelines. It has been approved by the Drugs Controller General of India (DCGI). It mentioned in the guidelines on what conditions the drug should be used.
Read also: Ocugen pays USD 15 million upfront to Bharat Biotech for Covaxin rights in Canada
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.